Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04061577 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04061577 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 1 participants.
The verdict
NCT04061577, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This proposal is a prospective, single-center, dose-escalation safety, tolerability, feasibility and potential efficacy study of transcranial direct current stimulation (tDCS) in acute stroke patients with substantial salvageable penumbra due to a large vessel occlusion before and after endovascular therapy.
Interventions
- DEVICE Transcranial Direct Current Stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-07-28 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04061577
The ClinicalTrials.gov registry entry for NCT04061577 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT04061577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04061577 about?
NCT04061577 is a clinical study titled "Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy". This proposal is a prospective, single-center, dose-escalation safety, tolerability, feasibility and potential efficacy study of transcranial direct current stimulation (tDCS) in acute stroke patients with substantial salvageable penumbra due to a large vessel occlusion before and after endovascular...
What is the current status of trial NCT04061577?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-07-28. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04061577?
The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT04061577?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.